Citation Impact
Citing Papers
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
2013 Standout
Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model
2004
The endocannabinoid nervous system
2001
Mutant G-protein-coupled receptors as a cause of human diseases
2004
The endocannabinoid system as a target for therapeutic drugs
2000
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
2001
Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling
2004
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
2005
Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor-1
2004
A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833
2005
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
Signal transduction through lipid second messengers
1996
Activation of Cannabinoid CB2Receptors Suppresses C-Fiber Responses and Windup in Spinal Wide Dynamic Range Neurons in the Absence and Presence of Inflammation
2004
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors
2001
Understanding Synapses: Past, Present, and Future
2008 StandoutNobel
The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1
2001
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
2005 Nature
Cannabinoid physiology and pharmacology: 30 years of progress
2004
Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin
2004
Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide
2001
The role of Cannabinoids in neurodegenerative diseases
2001
Pharmacological Actions of Cannabinoids
2005
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)
2004
The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling
1994
The synthetic cannabinoid WIN55212‐2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies
2001
Phospholipid signaling
1995
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases
2007
Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death
1996 Standout
Adverse Health Effects of Marijuana Use
2014 Standout
Sphingosine 1-Phosphate Rapidly Activates the Mitogen-activated Protein Kinase Pathway by a G Protein-dependent Mechanism
1995
Leptin-regulated endocannabinoids are involved in maintaining food intake
2001 Nature
Peripheral gating of pain signals by endogenous lipid mediators
2014
Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina
1999
Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide
2000
Vanilloid receptors on capsaicin‐sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries
2000
Central nervous system control of food intake and body weight
2006 StandoutNature
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
Endocannabinoids protect the rat isolated heart against ischaemia
2003
Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid
2002
Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” Ligands
2001
Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
2003
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract
2003
The orphan receptor GPR55 is a novel cannabinoid receptor
2007
Characterisation of the vasorelaxant properties of the novel endocannabinoid N‐arachidonoyl‐dopamine (NADA)
2004
Cardiovascular Pharmacology of Cannabinoids
2005
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
2008
The complexities of the cardiovascular actions of cannabinoids
2004
Newly Synthesized Phosphatidylinositol Phosphates Are Required for Synaptic Norepinephrine but Not Glutamate or γ-Aminobutyric Acid (GABA) Release
1998 StandoutNobel
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia–reperfusion by a novel cannabinoid mechanism
2005
Release of ceramide after membrane sphingomyelin hydrolysis decreases the basolateral secretion of triacylglycerol and apolipoprotein B in cultured human intestinal cells.
1993
Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2
2003
Cannabinoid signaling in glial cells
2004
Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis
2001
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart
2003
Apoptosis by Death Factor
1997 Standout
Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating Factor
2003
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
2004 StandoutNature
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions
2007
Coronary Vasodilator Effects of Endogenous Cannabinoids in Vasopressin-Preconstricted Unpaced Rat Isolated Hearts
2005
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
2004
The gastrointestinal pharmacology of cannabinoids
2001
Blood pressure regulation by endocannabinoids and their receptors
2005
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries
2004
Guillain–Barré Syndrome
2012 Standout
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain
2002
The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
2001
Sphingosine 1-phosphate receptors
2001
Context‐dependent effects of CB1 cannabinoid gene disruption on anxiety‐like and social behaviour in mice
2004
Differential Roles of de Novo Sphingolipid Biosynthesis and Turnover in the “Burst” of Free Sphingosine and Sphinganine, and Their 1-Phosphates and N-Acyl-Derivatives, That Occurs upon Changing the Medium of Cells in Culture
1995
(−)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens
2002
Molecular biology of cannabinoid receptors
2002
Aberrant cannabinoid signaling impairs oviductal transport of embryos
2004
6ʺ-Azidohex-2ʺ-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist
2004
Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens
1993 Nature
Endocannabinoids as cardiovascular modulators
2000
Targeting the cannabinoid system for pain relief?
2013
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety
2002
Rapid and Phosphoinositol-Dependent Binding of the SWI/SNF-like BAF Complex to Chromatin after T Lymphocyte Receptor Signaling
1998 Standout
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
1996 StandoutNature
The Formation of Ceramide-1-phosphate during Neutrophil Phagocytosis and Its Role in Liposome Fusion
1998 StandoutNobel
The stress-activated protein kinase subfamily of c-Jun kinases
1994 StandoutNature
Evidence of a novel site mediating anandamide‐induced negative inotropic and coronary vasodilatator responses in rat isolated hearts
2002
The endocannabinoid-CB1 receptor system in pre- and postnatal life
2004
The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs
2005
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock‐out mice
2004
Cardiovascular effects of cannabinoids
2002
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway
1995
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Passive Transfer of IgG Anti-GM1 Antibodies Impairs Peripheral Nerve Repair
2010
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
2005
Cannabinoids and Multiple Sclerosis
2007
Cell regulation by sphingosine and more complex sphingolipids
1991
Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli
2005
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
1998 StandoutNobel
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
1996 StandoutNature
TRP channels as cellular sensors
2003 StandoutNature
Involvement of CB1-receptors and β-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats
2004
Cellular signal transduction by anandamide and 2-arachidonoylglycerol
2000
Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test
2004
Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase
2005
Cannabinoids Acting on CB1 Receptors Decrease Contractile Performance in Human Atrial Muscle
2003
Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission
2007
Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors
2000
Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation
2002
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide
2000
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
1995 Standout
Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice
2000
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron
2002
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Formation of endogenous free sphingoid bases in cells induced by changing medium conditions
1994
Fumonisin Toxicity and Sphingolipid Biosynthesis
1996
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a “CB3” receptor
2003
Inhibition of acyl-CoA: cholesterol acyltransferase in chinese hamster ovary (CHO) cells by short-chain ceramide and dihydroceramide
1995
Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation
2003
Task specificity of cross-tolerance between Δ9-tetrahydrocannabinol and anandamide analogs in mice
2005
The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein
2000
A Predominant Role for Inhibition of the Adenylate Cyclase/Protein Kinase A Pathway in ERK Activation by Cannabinoid Receptor 1 in N1E-115 Neuroblastoma Cells
2003
Enhanced Phagocytosis through Inhibition of de Novo Ceramide Synthesis
2003 StandoutNobel
Cannabinoid receptors and the regulation of immune response
2000
CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents
2004
The identification of myriocin-binding proteins
1999
Effects on the Immune System
2005
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels
2003 Nature
The Fas Death Factor
1995 StandoutScience
The molecular logic of endocannabinoid signalling
2003 Standout
Noxious Cold Ion Channel TRPA1 Is Activated by Pungent Compounds and Bradykinin
2004 StandoutNobel
Vasodilator actions of abnormal‐cannabidiol in rat isolated small mesenteric artery
2003
Molecular Basis for Species-Specific Sensitivity to “Hot” Chili Peppers
2002 StandoutNobel
Inhibition of Carnitine Palmitoyltransferase I Augments Sphingolipid Synthesis and Palmitate-induced Apoptosis
1997 StandoutNobel
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
2006
Evidence That Ceramide Selectively Inhibits Protein Kinase C-α Translocation and Modulates Bradykinin Activation of Phospholipase D
1995
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanism
2005
Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of Mice
2002
Cannabinoid receptors and their ligands
2002
Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-α production by human mononuclear cells
2002
Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin‐like activity
2000
Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines
2004
Interaction of Ceramides, Sphingosine, and Sphingosine 1-Phosphate in Regulating DNA Synthesis and Phospholipase D Activity
1995
Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models
2003
Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus
2002
The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids
2005
Cannabinoids attenuate norepinephrine‐induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N‐acetyltransferase activity without involvement of cannabinoid receptors
2006
Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids
1993
Endocannabinoid-Mediated Control of Synaptic Transmission
2009
Emptying of intracellular Ca2+ stores releases a novel small messenger that stimulates Ca2+ influx
1993 StandoutNatureNobel
The endocannabinoid signalling system: Biochemical aspects
2005
Cannabinoid receptors on goldfish retinal bipolar cells: Electron-microscope immunocytochemistry and whole-cell recordings
2000
Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development
2000
Endocannabinoids and liver disease – review
2005
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
2006
Presynaptic Specificity of Endocannabinoid Signaling in the Hippocampus
2001
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
2001
The Super-Cooling Agent Icilin Reveals a Mechanism of Coincidence Detection by a Temperature-Sensitive TRP Channel
2004 StandoutNobel
Cannabinoid receptors in atherosclerosis
2006
Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: Roles in regulation of cardiovascular function
2002
Endocannabinoid system and stress and anxiety responses
2005
Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1
2004
Differential Regulation of Sphingomyelinase and Ceramidase Activities by Growth Factors and Cytokines
1995
Evidence for novel cannabinoid receptors
2005
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro
2005
Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals
1995
Endocannabinoids and the gut
2002
Cannabidiol: An Overview of Some Pharmacological Aspects
2002
T Cells at the Site of Autoimmune Inflammation Show Increased Potential for Trogocytosis
2013
Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis
1996
Cannabinoids and neuroinflammation
2004
A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo
2006
The ligand that came from within
2001
The quest for a vascular endothelial cannabinoid receptor
2002
Therapeutic Potential of Cannabinoids in CNS Disease
2003
Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana
1998
Sphingomyelin‐Derived Lipids Differentially Regulate the Extracellular Signal‐Regulated Kinase 2 (ERK‐2) and c‐Jun N‐Terminal Kinase (JNK) Signal Cascades in Airway Smooth Muscle
1996
Focal adhesion kinase (p125FAK) and paxillin are substrates for sphingomyelinase-induced tyrosine phosphorylation in Swiss 3T3 fibroblasts
1996
Activation of a Plasma Membrane–Associated Neutral Sphingomyelinase and Concomitant Ceramide Accumulation During IgG-Dependent Phagocytosis in Human Polymorphonuclear Leukocytes
1998 StandoutNobel
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death
2000
Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis
2007
Sphingosine inhibits phosphatidate phosphohydrolase in human neutrophils by a protein kinase C-independent mechanism
1991
The therapeutic potential of the cannabinoids in neuroprotection
2002
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
2005
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction
2003
The neurobiology and evolution of cannabinoid signalling
2001
Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation.
1991
Systemic and portal hemodynamic effects of anandamide
2001
Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts
1994
Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome
2009
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
2006
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
1995 StandoutScience
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase.
1994
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
2012
G Protein-coupled Endothelial Receptor for Atypical Cannabinoid Ligands Modulates a Ca2+-dependent K+ Current
2003
Cannabinoid CB1 receptors and ligands in vertebrate retina: Localization and function of an endogenous signaling system
1999
Role of Endogenous Cannabinoids in Synaptic Signaling
2003
Sphingosine-1-phosphate, a metabolite of sphingosine, increases phosphatidic acid levels by phospholipase D activation
1992
Microinjection of a cannabinoid receptor antagonist into the NTS increases baroreflex duration in dogs
2003
Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation
2011
Ceramide does not mediate the effect of tumour necrosis factor α on superoxide generation in human neutrophils
1994
Programmed Cell Death Induced by Ceramide
1993 StandoutScience
Activation of a Plasma Membrane–Associated Neutral Sphingomyelinase and Concomitant Ceramide Accumulation During IgG-Dependent Phagocytosis in Human Polymorphonuclear Leukocytes
1998 StandoutNobel
Sphingosine Blocks Human Polymorphonuclear Leukocyte Phagocytosis Through Inhibition of Mitogen-Activated Protein Kinase Activation
1999 StandoutNobel
Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme
1991 Standout
Functions of Ceramide in Coordinating Cellular Responses to Stress
1996 StandoutScience
Integrins and Signal Transduction Pathways: the Road Taken
1995 StandoutScience
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
1997 StandoutScience
Mechanism of Cannabinoid Effects on Long-Term Potentiation and Depression in Hippocampal CA1 Neurons
1999
Inhibition of tumor angiogenesis by cannabinoids
2003
Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts.
1994
Cannabinoids in health and disease
2007
Functional CB1 cannabinoid receptors in human vascular endothelial cells
2000
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
2002 StandoutScience
Endocannabinoid Signaling in the Brain
2002 Science
Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions.
1990
Ceramide Inhibits IgG-Dependent Phagocytosis in Human Polymorphonuclear Leukocytes
1997 StandoutNobel
The Science of Marijuana
2007
Cannabinoids and the gastrointestinal tract
2001
Endocannabinoids and Neuroprotection
2002
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
[51] Enzymes of ceramide biosynthesis
1992
CB 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids
2005
Activation of CB 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
2003
Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility
2006
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent
2002
Vascular targets for cannabinoids: animal and human studies
2013
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
1999
PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid.
1995
Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice
2002
Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration
2003
Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain
2001
N-arachidonoyll -serine, an endocannabinoid-like brain constituent with vasodilatory properties
2006
The sphingomyelin cycle and the second messenger function of ceramide.
1994
Function of PI3Kγ in Thymocyte Development, T Cell Activation, and Neutrophil Migration
2000 StandoutScienceNobel
The Endocannabinoid System and the Brain
2012
Peripheral cannabinoid receptor, CB2, regulates bone mass
2006
Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors
2004
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
2004
Endocannabinoids and Vascular Function
2000
Activation of the Sphingomyelin Cycle Through the Low-Affinity Neurotrophin Receptor
1994 Science
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
2001
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
2005 Science
Anandamide-Induced Depressor Effect in Spontaneously Hypertensive Rats
2003
Sphingolipid metabolites: Members of a new class of lipid second messengers
1995
Multiple Functions of Endocannabinoid Signaling in the Brain
2012
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
1996 StandoutScience
Works of Nancy E. Buckley being referenced
The role of calcium influx in cellular proliferation induced by interaction of endogenous ganglioside GM1 with the B subunit of cholera toxin
1995
Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat
1997
Formation of B and T cell subsets require the cannabinoid receptor CB2
2006
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
2000
The peripheral cannabinoid receptor knockout mice: an update
2007
Role of cannabinoid receptors in inhibiting macrophage costimulatory activity
2004
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
2008
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells
2007
CB2 cannabinoid receptor mediation of antinociception
2006
The Bimodal growth response of swiss 3T3 cells to the B subunit of cholera toxin is independent of the density of its receptor, ganglioside GM1
1990
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
1999
Sphingosine stimulates cellular proliferation via a protein kinase C-independent pathway.
1990
Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts.
1993
Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts.
1992